CancerNCT06237816
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
A study testing Patient Education Intervention and Provider Education Intervention in people with Cancer and Oncology, run by University of Hawaii at 3 sites in United States.
Trial summary
The overall goal of the project is to pilot test CTNow, a multilevel intervention designed to facilitate access and referrals to cancer clinical trials in rural areas through patient and provider education and teleconference resources. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- What is being tested?
- Patient Education Intervention and Provider Education Intervention
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 3 sitesUnited States
- Study dates
- 1 May 2025to Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Patients must have been diagnosed with any cancer.
- Patients who have received treatment, are receiving cancer treatment at the time of enrollment, or estimated to start treatment within 90 days.
- Patients must be ≥ 18 years of age. Patients must be able to read, write, and speak English. Study materials and telephone calls are only available in English.
- Patients must be residents of Hawaii, Kauai, or Maui counties.
Who cannot join
- Patients must not have previously participated in a cancer clinical trial. Those who have participated in a cancer clinical trial are not eligible for the study.
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United States3 sites, 3 recruiting
- Recruiting
Hilo Benioff Medical Center
Hilo, Hawaii, 96720
Izumi Okado, (808) 564-5978, iokado@cc.hawaii.edu
- Recruiting
Univesity of Hawaii Cancer Center
Honolulu, Hawaii, 96813
Aaron Roberts, 5857309892, aroberts@cc.hawaii.edu
Tomomi Otaki, totaki@cc.hawaii.edu
- Recruiting
Wilcox Medical Center
Lihue, Hawaii, 96766
Izumi Okado, (808) 564-5978, iokado@cc.hawaii.edu
About this study
The overall goal of the project is to pilot test CTNow, a multilevel intervention designed to facilitate access and referrals to cancer clinical trials in rural areas through patient and provider education and teleconference resources.
- Being tested
- Patient Education Intervention, Provider Education Intervention
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patient Education InterventionOther
Multimedia Educational Videos
Provider Education InterventionOther
Provider workshops via zoom
| Study group | Role | What they receive |
|---|---|---|
| Patient Education Intervention | Experimental | A multimedia educational series is designed to provide patient education on cancer clinical trials.
The following topics are addressed:
* What is a clinical trial?
* Types of clinical trials.
* Phases of clinical trials.
* Benefits and drawbacks.
* Costs.
* FAQs. This section covers common myths and clarifies these myths using a Q\&A format.
* How to join a clinical trial. Information about eligibility and informed consent.
* Clinical trial stories. Testimonies from oncology providers and patients. Each module is approximately 2-5 minutes, and they can be reviewed in the order/schedule preferred by the patient.
The overall program is 30 minutes to view including the videos. The tablet provided to patients provides additional benefits for participation. Receives: Other: Patient Education Intervention |
| Provider Education Intervention | Experimental | The provider education intervention will consist of 3 provider informational sessions conducted individually. These individual provider sessions will be conducted by teleconference by the research team and scheduled according to provider's availability.
Provider workshops are designed to provide both a background on clinical trial infrastructure in Hawaii and resources for additional information. The content of these sessions includes:
* An overview of clinical trials infrastructure in Hawaii.
* Available trials in Hawaii. At each informational session, the research team will review available trials and any new/upcoming trials with the provider.
* An overview of how to get involved in clinical trials. As experience and background re: clinical trials may vary across providers, the content of these informational sessions will be tailored to each provider. Following the initial session, 2 additional meetings will be scheduled in 4-6 months as follow-up sessions. Receives: Other: Provider Education Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in patients' awareness and knowledge of clinical trials
Participants will complete a 12-item awareness and knowledge of clinical trials questionnaire at baseline and post-intervention. Items are reported on a Likert-type scale , with higher scores indicating greater knowledge. A paired t-test will be used to evaluate whether there is a statistically significant difference in pre- and post-intervention scores on patients' knowledge of clinical trials.
Measured: 18 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Feb 2024
- Study start1 May 2025
- Primary completionJul 2026 (estimated)
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Hawaii
- Sponsor type
- University, hospital or other
- Collaborators
- Agency for Healthcare Research and Quality (AHRQ)
- Responsible party
- Sponsor
- Investigators
- Izumi Okado, PhD, Principal investigator, University of Hawaii Cancer Research Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06237816
- Sponsor's protocol ID
- Okado-2023-2
- Status last verified
- Mar 2026
- First submitted
- 7 Dec 2023
- Last updated
- 3 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
- ClinicalTrials.gov ID
- NCT06237816
- Acronym / sponsor ID
- Okado-2023-2
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- University of HawaiiUniversity, hospital or other
- Collaborators
- Agency for Healthcare Research and Quality (AHRQ)
- Study start
- 1 May 2025 (actual)
- Primary completion
- Jul 2026 (estimated)
- Study completion
- Dec 2026 (estimated)
- First posted
- 2 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The overall goal of the project is to pilot test CTNow, a multilevel intervention designed to facilitate access and referrals to cancer clinical trials in rural areas through patient and provider education and teleconference resources.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patient Education Intervention | Experimental | Other: Patient Education InterventionA multimedia educational series is designed to provide patient education on cancer clinical trials. The following topics are addressed: * What is a clinical trial? * Types of clinical trials. * Phases of clinical trials. * Benefits and drawbacks. * Costs. * FAQs. This section covers common myths and clarifies these myths using a Q\&A format. * How to join a clinical trial. Information about eligibility and informed consent. * Clinical trial stories. Testimonies from oncology providers and patients. Each module is approximately 2-5 minutes, and they can be reviewed in the order/schedule preferred by the patient. The overall program is 30 minutes to view including the videos. The tablet provided to patients provides additional benefits for participation. |
| Provider Education Intervention | Experimental | Other: Provider Education InterventionThe provider education intervention will consist of 3 provider informational sessions conducted individually. These individual provider sessions will be conducted by teleconference by the research team and scheduled according to provider's availability. Provider workshops are designed to provide both a background on clinical trial infrastructure in Hawaii and resources for additional information. The content of these sessions includes: * An overview of clinical trials infrastructure in Hawaii. * Available trials in Hawaii. At each informational session, the research team will review available trials and any new/upcoming trials with the provider. * An overview of how to get involved in clinical trials. As experience and background re: clinical trials may vary across providers, the content of these informational sessions will be tailored to each provider. Following the initial session, 2 additional meetings will be scheduled in 4-6 months as follow-up sessions. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Patients must have been diagnosed with any cancer.
- Patients who have received treatment, are receiving cancer treatment at the time of enrollment, or estimated to start treatment within 90 days.
- Patients must be ≥ 18 years of age. Patients must be able to read, write, and speak English. Study materials and telephone calls are only available in English.
- Patients must be residents of Hawaii, Kauai, or Maui counties.
Key exclusion criteria (1 listed)
- Patients must not have previously participated in a cancer clinical trial. Those who have participated in a cancer clinical trial are not eligible for the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patient Education InterventionMultimedia Educational Videos | Other | Patient Education Intervention |
| Provider Education InterventionProvider workshops via zoom | Other | Provider Education Intervention |
Primary outcome
Change in patients' awareness and knowledge of clinical trials
Time frame: 18 months
Participants will complete a 12-item awareness and knowledge of clinical trials questionnaire at baseline and post-intervention. Items are reported on a Likert-type scale , with higher scores indicating greater knowledge. A paired t-test will be used to evaluate whether there is a statistically significant difference in pre- and post-intervention scores on patients' knowledge of clinical trials.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Izumi Okado, PhD principal investigator
University of Hawaii Cancer Research Center
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Patient Education Intervention and Provider Education Intervention in people with Cancer and Oncology, run by University of Hawaii at 3 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Izumi Okado, PhD ((808) 564-5978, iokado@cc.hawaii.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in patients' awareness and knowledge of clinical trials (time frame: 18 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2026.